AI article

Finding New Drugs Is Laborious. This AI Startup Is Skipping The Lab Work

Publisher description: Potential Sciences, a startup backed by the UK government, is betting that training AI models on computer-generated biochemical data can speed up the plodding process of developing new drugs.

Wired | Nov 5, 2026 | Joel Khalili

Automated excerpt

Potential Sciences plans to build large-scale chemical datasets by using basic principles of physics to simulate interactions between atoms, then small molecules, then complex amino acids and proteins. The hope among startups like Potential Sciences is that drug discovery will be one of the first scientific frontiers to be transformed by the technology. Potential Sciences doesn’t yet have all the answers.

Selected automatically from source text; not independently written or fact-checked. Read the original for full context.

Read the original article

Read next

AI briefing: recent picks

More stories to explore